dc.contributor.author | Koffas, A | en_US |
dc.contributor.author | Mak, L-Y | en_US |
dc.contributor.author | Gill, US | en_US |
dc.contributor.author | Kennedy, PTF | en_US |
dc.date.accessioned | 2022-08-25T12:52:12Z | |
dc.date.available | 2022-04-22 | en_US |
dc.date.issued | 2022 | en_US |
dc.identifier.other | ARTN 900 | |
dc.identifier.other | ARTN 900 | |
dc.identifier.other | ARTN 900 | en_US |
dc.identifier.other | ARTN 900 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/80164 | |
dc.relation.ispartof | VIRUSES-BASEL | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | HBeAg-positive chronic hepatitis B | en_US |
dc.subject | HBeAg-positive chronic infection | en_US |
dc.subject | immune tolerant disease phase | en_US |
dc.title | Early Treatment Consideration in Patients with Hepatitis B 'e' Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift? | en_US |
dc.type | Article | |
dc.identifier.doi | 10.3390/v14050900 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000801537300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 14 | en_US |